Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Profile of High-Frequency Use of a Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment

NCT07336056 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT07336056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07336056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Profile of High-Frequency Use of a Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment
Lead sponsor
Theranica
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 8, 2026
Completion date
January 30, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine